Silver Book Fact

Major cardiovascular event rates could be reduced by 80% simply by acting on known risk factors with therapies already shown to be effective.

Califf, Robert M., Robert A. Harrington, Leanne K. Madre, Eric D. Peterson, Deborah Roth, and Kevin A. Schulman. Curbing The Cardiovascular Disease Epidemic: Aligning industry, government, payers, and academics. Health Affairs. 2007; 26(1): 62-74

Reference

Title
Curbing The Cardiovascular Disease Epidemic: Aligning industry, government, payers, and academics
Publication
Health Affairs
Publisher
Project HOPE
Publication Date
2007
Authors
Califf, Robert M., Robert A. Harrington, Leanne K. Madre, Eric D. Peterson, Deborah Roth, and Kevin A. Schulman
Volume & Issue
Volume 26, Issue 1
Pages
62-74

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Aspirin as stroke prevention
    Aspirin reduces stroke rate by 20% in patients with myocardial infarction.  
  • Aspirin, beta-blockers, angiotensin-converting enzyme inhibitors, and statins, when taken in combination, have been estimated to reduce the relative risk of coronary heart disease mortality by 80%, compared with a placebo.  
  • The development of antioxidants that reduce oxidative damage is underway. One antioxidant that has been found, uric acid, has an even greater protective effect when combined with tPA.  
  • According to the National Institutes of Health, use of the clot-busting drug t-PA saves $4,400 per patient in hospitalization and nursing home costs.  
  • Effectiveness of pacemaker/defibrillators to control AFib
    Widespread use of pacemaker/defibrillators to control atrial fibrillation could result in a 50% decrease in stroke.